Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus.
Bell
D S
DS
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001786:Blood Glucose / Q000187:drug effects; D002227:Carbazoles / Q000494:pharmacology; D000077261:Carvedilol; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D011412:Propanolamines / Q000494:pharmacology; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001786:Blood Glucose; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol